Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
9.55
+0.32 (3.47%)
Aug 5, 2025, 4:00 PM - Market closed
Ligand Pharmaceuticals Market Cap
Arcus Biosciences has a market cap or net worth of $1.01 billion as of August 5, 2025. Its market cap has decreased by -24.52% in one year.
Market Cap
1.01B
Enterprise Value
87.20M
1-Year Change
-24.52%
Ranking
Category
Stock Price
$9.55
Market Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $704.52M to $1.01B, an increase of 43.53%. That is a compound annual growth rate of 5.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 977.32M | -28.28% |
| Dec 31, 2024 | 1.36B | -4.70% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | 1.69B | 263.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |